ATI Physical Therapy Corp (ATIP) - Price-to-Projected Revenue Ratio

ATI Physical Therapy Inc. (ATIP) - corporate logo

ATI Physical Therapy relies on an extensive network of clinics across various states and partnerships within the B2B sector. The company is implementing energy-saving technologies and principles of social accessibility in healthcare. The forward P/S ratio demonstrates the business valuation dynamics, while 0.00 shows the current value of this metric. Stable demand for rehabilitation supports cash flow despite rising personnel costs.

ATI Physical Therapy Corp - ATIP Forward Price to Sales (period 07/04/2022 - 12/07/2024)

Analytical breakdowns for ATI Physical Therapy

Comprehensive company analysis:ATI Physical Therapy Corp ATIP
Original product of atipt.com

Investors in ATI Physical Therapy (ATIP) must understand the business's fair value through the lens of future cash flows. This forward price-to-sales ratio reflects the relationship between market capitalization and expected sales, allowing investors to filter out market noise from real trends, which is critical for clinics facing rising operating costs for rent and personnel amid US inflation.

Competitors of ATI Physical Therapy (ATIP)

HCA Healthcare - Forward Price-to-Revenue Multiple|Forward Price to Sales THC|FMS - Price-to-Projected Revenue Ratio|Future Price to Revenue SOLV|EHC: Forward P/S Multiple|Universal Health Services, Inc. - Forward Price to Sales|Forward Price-to-Revenue Multiple DVA|Market Cap to Future Revenue Ratio RadNet Inc RDNT|Price-to-Projected Revenue Ratio Option Care Health Inc (OPCH)|Market Cap to Expected Sales Ratio Surgery Partners Group|Forward P/S Multiple PINC (Premier, Inc.)|Market Cap to Expected Sales Ratio nationalvision.com (EYE)|Progyny - Forward P/S Multiple|Ardent Health (ARDT) - Forward Price-to-Revenue Multiple|SEM: Forward P/S Multiple|Astrana Corp (ASTH) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Pediatrix Corp|Price-to-Projected Revenue Ratio USPH|Forward Price-to-Revenue Multiple PNTG (The Pennant Group)|ORGO (Organogenesis Holdings Inc.) - Forward Price to Sales|Nutex Health Corp - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio AUNA (Auna Corp)|SBC Medical Corp - Forward P/S Multiple|Forward Price to Sales EOLS (evolus.com)|CYH: Forward P/S Multiple|Market Cap to Future Revenue Ratio BeautyHealth (SKIN)|Price-to-Projected Revenue Ratio MediWound Ltd|BTMD: Forward Price to Sales|Forward P/S Multiple JYNT|Forward P/S Multiple docgo.com (DCGO)|Price-to-Projected Revenue Ratio P3 Health Partners PIII|GANX (Gain Therapeutics Inc.) - Future Price to Revenue|EUDA: Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio Basel Medical Group|CLGN: Forward P/S Multiple|cuprina.com.sg (CUPR) - Forward P/S Multiple|Forward Price-to-Revenue Multiple CCM|AMS (American Shared Hospital Services Inc) - Price to Expected Revenue Ratio|Forward P/S Multiple MRM|Market Cap to Expected Sales Ratio avalon-globocare.com|Price-to-Projected Revenue Ratio DIH Holding US, Inc. DHAI|XAGE (carmellcosmetics.com) - Future Price to Revenue|NIVF: Forward Price-to-Revenue Multiple|CareMax Inc. - Price to Expected Revenue Ratio|Kindly MD Corp (KDLY) - Price-to-Projected Revenue Ratio|ModivCare Corp - Forward Price to Sales|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|Market Cap to Future Revenue Ratio SunLink Health Systems, Inc SSY|Forward P/S Multiple BACK